Eye drops could replace needles for blinding eye disease?
NCT ID NCT06704009
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-phase trial tested NT-101 eye drops in 20 people with wet age-related macular degeneration (AMD), a leading cause of vision loss. The study aimed to check safety and see if the drops could reduce fluid buildup and improve vision. Participants received either a low or high dose of the eye drops for 8 weeks.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
NT-101 topical ophthalmic solution (eye drops)
What this could lead to
If successful, this could point toward a non-invasive eye drop treatment for wet AMD, potentially reducing the need for frequent eye injections.
What could go wrong
This is a very early, small trial (20 people) focused on safety. It is not designed to prove the treatment works, and many early-stage eye drop therapies fail to show benefit in larger studies.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for WET AGE RELATED MACULAR DEGENERATION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Duke Eye Center
Durham, North Carolina, 27705, United States
-
Elman Retina Group
Rosedale, Maryland, 21237, United States
-
Erie Retina Research
Erie, Pennsylvania, 16505, United States
-
Texas Retina Associates
Dallas, Texas, 75231, United States